miDiagnostics

Last Round
Series DDec 2024
Rounds
3

About

miDiagnostics is a Diagnostics company. Its most recent funding was a Series D round in Dec 2024. Investors include Alychlo and Thermo Fisher Scientific.

Funding History

Series DSeries DDec 2024

Sign up to see all 3 events

Funding: Venture Round through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Function Health

Function Health offers annual lab testing and personalized health insights, helping members track...

Austin, United States201–500Diagnostics, Healthcare
Growth EquityTotal funding$839.0MJul 2026
Ginkgo BioworksIPO

Ginkgo Bioworks operates autonomous laboratories that use robotics to run experimental work, help...

Boston, United States501–1000Automation, Diagnostics
Extension RoundTotal funding$790.0MMay 2020
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
ConvertibleTotal funding$550.1MAug 2025
LetsGet CheckedMerged

LetsGetChecked provides at-home testing, virtual consultations, prescription fulfillment, and cli...

Dublin, Ireland501–1000Diagnostics, Healthcare
Series FTotal funding$448.0MJan 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

miDiagnostics on Indexed.vc
<a href="https://indexed.vc/companies/midiagnostics"><img src="https://indexed.vc/api/badge/company/midiagnostics" alt="miDiagnostics on Indexed.vc" width="260" height="76" /></a>